Group Wijnen

Medicijnen en Levenswetenschappen

1. Pediatrics 100%
2. Wilms Tumor 95%
3. Netherlands 82%
4. Child 70%
5. Neoplasms 60%
6. Kidney 48%
7. Rhabdomyosarcoma 44%
8. Neuroblastoma 34%
9. Systematic Reviews 33%
10. Augmented Reality 33%
11. Nephrons 27%
12. Germ Cell and Embryonal Neoplasms 27%
13. Meta-Analysis 25%
14. Cohort Studies 24%
15. Surgical Oncology 23%
16. Survival 23%
17. Sarcoma 22%
18. Central Venous Catheters 20%
19. Extremities 19%
20. Nephrectomy 17%
21. Recurrence 16%
22. Practice Guidelines 16%
23. Incidence 15%
24. Neurofibrosarcoma 15%
25. taurolidine 15%
26. Myofibroma 15%
27. Fluorescence 14%
28. Magnetic Resonance Imaging 13%
29. Surgeons 13%
30. Organoids 13%
31. Therapeutics 12%
32. Nervous System Neoplasms 12%
33. Indocyanine Green 11%
34. Teratoma 11%
35. Hepatoblastoma 11%
36. Databases 11%
37. Large-Core Needle Biopsy 11%
38. Hirschsprung Disease 11%
39. Neurofibromatoses 11%
40. Catheter-Related Infections 11%
41. Intussusception 10%
42. Sentinel Lymph Node 10%
43. Intensity-Modulated Radiotherapy 10%
44. Pediatric Intensive Care Units 10%
45. Appendectomy 10%
46. Lymph Nodes 10%
47. Ewing's Sarcoma 10%
48. Salvage Therapy 10%
49. Medical Oncology 10%
50. Technetium 10%
51. Arteriovenous Malformations 9%
52. Gene Fusion 9%
53. Appendicitis 9%
54. Workflow 9%
55. Brachytherapy 9%
56. Population 9%
57. Quality of Life 9%
58. Feasibility Studies 9%
59. Hodgkin Disease 8%
60. Osteosarcoma 8%
61. Fine Needle Biopsy 8%
62. Histology 8%
63. Surgical Instruments 8%
64. Coloring Agents 8%
65. Tumor Burden 8%
66. Retrospective Studies 8%
67. Uterine Cervical Neoplasms 8%
68. Drug Therapy 7%
69. Needles 7%
70. Critical Care 7%
71. Guidelines 7%
72. Cell Biology 7%
73. Neurofibromatosis 1 7%
74. Young Adult 7%
75. Fasting 6%
76. Catheters 6%
77. Fibrosarcoma 6%
78. Medical Records 6%
79. Margins of Excision 6%
80. Neoplasm Metastasis 6%
81. Whole Exome Sequencing 6%
82. Technology 6%
83. RNA Sequence Analysis 6%
84. Endodermal Sinus Tumor 5%
85. Pain 5%
86. Registries 5%
87. Survival Rate 5%
88. Magnetic Resonance Spectroscopy 5%
89. Datasets 5%